Moderna's stock experienced a significant increase of 57% after the announcement of positive trial results for a personalized cancer vaccine developed in collaboration with Merck, which saw its shares rise over 6%. The timeline for U.S. approval applications remains uncertain.
Keysight Technologies reported third-quarter earnings of $3.07 per share, surpassing the expected $2.48, with revenue of $1.85 billion also exceeding estimates. In contrast, Lowe's shares fell 2% after it revised its full-year sales and earnings outlook to the lower end of previous guidance, citing pressure in home improvement spending.
Target's stock declined 1.5% despite better-than-expected revenues, boosted by tariff refunds, while La-Z-Boy's shares plummeted nearly 17% due to a 9% drop in first-quarter earnings and a revenue forecast that fell short of expectations.
Mercury Systems' shares dropped over 9% after its fourth-quarter earnings missed consensus estimates, despite projecting revenue for the fiscal year ending June 2027 to be around $1.1 billion. Toll Brothers saw a modest rise of just over 1% after reporting earnings and revenues that exceeded analyst expectations.
Estee Lauder's shares rose more than 7% following a strong fiscal fourth-quarter performance, with earnings guidance for fiscal year 2027 aligning with analyst estimates. Analog Devices also saw a 3% increase after reporting better-than-expected earnings and revenue, along with improved gross margins